Status:
UNKNOWN
Non-invasive Neuromodulation Guided Through Biomarkers in Patients With Stroke Sequels
Lead Sponsor:
Universidade Federal de Pernambuco
Conditions:
Stroke
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This study aims to investigate if the size effect of repetitive magnetic transcranial stimulation in the paretic upper limb in patients after stroke is influenced by the therapeutic decision.
Detailed Description
After the patients and volunteers signed an informed consent form they will be classified and randomized using a website (randomization.com) by a non-involved researcher. All patients and volunteers ...
Eligibility Criteria
Inclusion
- More than 3 months after stroke;
- Ischemic or hemorrhagic stroke with upper limb motor impairment;
Exclusion
- Any contraindication for application of transcranial magnetic stimulation;
- Peripheral lesions in the assessed upper limb;
- Score ≤ 18 at Folstein Mini Mental State Examination;
- Alteration of drugs that alter the excitability of the cortex (in less than 3 months);
- Application of botulinum toxin in less than 6 months.
Key Trial Info
Start Date :
March 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04816305
Start Date
March 29 2021
End Date
June 30 2024
Last Update
May 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Federal University of Pernambucano
Recife, Pernambuco, Brazil, 50740-560